Pharmacy- Page 23

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

FDA Accepts Amgen’s Supplemental Biologics License Application To Expand Indication For XGEVA

The FINANCIAL -- Amgen on June 19 announced that the U.S. Food and Drug Administration (FDA) has accepted the XGEVA (denosumab) supplemental Biologics License Application (sBLA) that seeks to expand the currently approved indication for the prevention of fractures and other skeletal-related

by The FINANCIAL

June 20, 2017

1 min read

Pharmacy

Bristol-Myers Squibb to Sell Manufacturing Facility in Swords, Ireland to SK Biotek Co., Ltd.

The FINANCIAL -- Bristol-Myers Squibb Company and SK Biotek Co., Ltd. on June 16 announced the companies have signed a definitive purchase agreement to sell Bristol-Myers Squibb’s small molecule active pharmaceutical ingredient manufacturing facility in Swords, Ireland, to SK Biotek, a wholly-owned

by The FINANCIAL

June 16, 2017

2 mins read

Pharmacy

Johnson & Johnson Announces Completion of Acquisition of Actelion

The FINANCIAL -- Johnson & Johnson on June 16 announced the completion of the acquisition of Actelion Ltd for a total purchase price of approximately $30 billion in cash.

by The FINANCIAL

June 16, 2017

1 min read

Pharmacy

Pfizer Receives Exclusive Commercialization Rights in Europe for CRESEMBA

The FINANCIAL -- Pfizer Inc. and Basilea Pharmaceutica Ltd., an international biopharmaceutical company specializing in the research and development of anti-infective and oncological medicines, on June 14 announced they have entered into an agreement whereby Pfizer will be granted the exclusive commercialization

by The FINANCIAL

June 15, 2017

1 min read

Pharmacy

Pfizer and Lilly Receive FDA Fast Track Designation for Tanezumab

The FINANCIAL -- Pfizer Inc. and Eli Lilly and Company on June 13 announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for tanezumab for the treatment of chronic pain in patients with osteoarthritis (OA) and chronic

by The FINANCIAL

June 13, 2017

1 min read

Pharmacy

Teva Announces Launch of Generic Zetia in the United States

The FINANCIAL -- Teva Pharmaceutical Industries Ltd., on June 12 announced the launch of generic Zetia®1 (ezetimibe) tablets, 10 mg, in the U.S.

by The FINANCIAL

June 13, 2017

1 min read

Pharmacy

Gilead Says Regimen May Have Potential To Advance Triple-therapy HIV Treatment

The FINANCIAL -- Gilead Sciences, Inc. on June 12 announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for an investigational, once-daily single tablet regimen containing bictegravir (50 mg) (BIC), a novel investigational

by The FINANCIAL

June 12, 2017

1 min read

Pharmacy

AstraZeneca Presents New Data On Farxiga

The FINANCIAL -- AstraZeneca presented new data at the American Diabetes Association’s (ADA) 77th Scientific Sessions underpinning the safety profile of Farxiga (dapagliflozin) with an analysis of data pooled from dapagliflozin clinical trials1, as well as three new cardiovascular (CV) outcomes analyses

by The FINANCIAL

June 12, 2017

2 mins read

Pharmacy

Empagliflozin (Jardiance) to be studied in chronic kidney disease

The FINANCIAL -- Boehringer Ingelheim and Eli Lilly and Company on June 12 announced to conduct a new, large clinical outcomes trial investigating empagliflozin for the treatment of people with chronic kidney disease.

by The FINANCIAL

June 12, 2017

1 min read

Pharmacy

Sanofi and Regeneron Announce Positive Results from First Dedicated Studies Evaluating Praluent

The FINANCIAL -- Sanofi and Regeneron Pharmaceuticals, Inc. on June 11 announced positive results from two Phase 3b/4 ODYSSEY-DM trials in patients with diabetes.

by The FINANCIAL

June 12, 2017

3 mins read